Skip to main content

Table 1 The association of GDF15 and CA125 with the clinicopathologic parameters in the EOC patients

From: GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

 

n

GDF15(pg/mL)

CA125(U/L)

median

IQRa

pb

median

IQRa

pb

Age

  ≤ 50 y

50

824.7

719.1

0.498

31.8

97.4

0.162

  > 50 y

72

990.6

767.6

 

73.0

399.9

 

Histology

 Serous

90

920.9

667.5

0.784

60.4

345.7

0.418

 Nonserous

32

923.6

1397.8

 

35.2

231.8

 

Grade

 Low/Medium

41

923.5

715.2

0.496

67.2

448.4

0.122

 High

81

912.5

898.8

 

39.7

99.74

 

FIGO

 I/II

13

604.6

719.0

0.088

22.9

19.1

0.005

 III/IV

109

943.2

753.5

 

61.0

348.5

 

LN metastasis

 Yes

69

994.0

748.1

0.033

107.3

427.9

0.005

 No

53

784.7

770.6

 

29.1

107.5

 
  1. a. IQR: the interquartile range
  2. b. The p value was calculated using Mann-Whitney test method
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us